chr1-111318579-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_201653.4(CHIA):c.816C>A(p.Ile272Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00535 in 1,614,194 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 36 hom. )
Consequence
CHIA
NM_201653.4 synonymous
NM_201653.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.121
Genes affected
CHIA (HGNC:17432): (chitinase acidic) The protein encoded by this gene degrades chitin, which is found in the cell wall of most fungi as well as in arthropods and some nematodes. The encoded protein can also stimulate interleukin 13 expression, and variations in this gene can lead to asthma susceptibility. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 1-111318579-C-A is Benign according to our data. Variant chr1-111318579-C-A is described in ClinVar as [Benign]. Clinvar id is 782080.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.121 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 36 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00388 AC: 590AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
590
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00461 AC: 1159AN: 251396 AF XY: 0.00456 show subpopulations
GnomAD2 exomes
AF:
AC:
1159
AN:
251396
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00551 AC: 8051AN: 1461870Hom.: 36 Cov.: 32 AF XY: 0.00531 AC XY: 3860AN XY: 727234 show subpopulations
GnomAD4 exome
AF:
AC:
8051
AN:
1461870
Hom.:
Cov.:
32
AF XY:
AC XY:
3860
AN XY:
727234
Gnomad4 AFR exome
AF:
AC:
25
AN:
33480
Gnomad4 AMR exome
AF:
AC:
104
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
49
AN:
26136
Gnomad4 EAS exome
AF:
AC:
1
AN:
39700
Gnomad4 SAS exome
AF:
AC:
120
AN:
86256
Gnomad4 FIN exome
AF:
AC:
643
AN:
53420
Gnomad4 NFE exome
AF:
AC:
6797
AN:
1111994
Gnomad4 Remaining exome
AF:
AC:
308
AN:
60392
Heterozygous variant carriers
0
424
848
1271
1695
2119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00387 AC: 590AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.00416 AC XY: 310AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
590
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
310
AN XY:
74472
Gnomad4 AFR
AF:
AC:
0.000793651
AN:
0.000793651
Gnomad4 AMR
AF:
AC:
0.00281082
AN:
0.00281082
Gnomad4 ASJ
AF:
AC:
0.00259217
AN:
0.00259217
Gnomad4 EAS
AF:
AC:
0.000193349
AN:
0.000193349
Gnomad4 SAS
AF:
AC:
0.000621633
AN:
0.000621633
Gnomad4 FIN
AF:
AC:
0.010929
AN:
0.010929
Gnomad4 NFE
AF:
AC:
0.00551114
AN:
0.00551114
Gnomad4 OTH
AF:
AC:
0.00473485
AN:
0.00473485
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 08, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at